BRITAIN APPROVES ASTRA/OXFORD COVID VACCINE
LONDON Britain on Wednesday became the first country to approve the coronavirus vaccine developed by Oxford University and Astrazeneca, hoping that rapid action will help it stem a record surge of infections driven by a highly contagious form of the virus.
The Astrazeneca/oxford shot has been plagued with questions about its most effective dosage ever since data published last month showed some surprising results.
While other regulators have taken a more cautious approach, Britain's MHRA was at pains to say it had resolved early doubts and — unexpectedly — that it had found an 80 per cent success rate for the administration of two full doses, three months apart, higher than the average that the developers themselves had found.
Health Canada says it needs more information before it can make a decision on the vaccine.